J M Fleming1, E Ginsburg, C W McAndrew
1Mammary Biology and Tumorigenesis Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. jodie.fleming@nccu.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study identifies a novel prolactin receptor (PrlR) splice variant, Δ7/11, that binds prolactin. This interaction inhibits prolactin-driven breast cell proliferation and alters cell cycle regulation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: